(Q46138563)

English

Naloxone in tardive dyskinesia

scientific article published in January 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

Naloxone in tardive dyskinesia (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

1 reference

based on heuristic

inferred from title

author name string

I Blum

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

P F Nisipeanu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

E Roberts

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

93

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

538

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

https://scigraph.springernature.com/pub.10.1007/bf00207250

0 references

Naloxone treatment of L-dopa-induced dyskinesias in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naloxone and tardive dyskinesia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naloxone may be beneficial in the treatment of tardive dyskinesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of naloxone on the neuropsychiatric symptoms of a woman with partial adrenal 21-hydroxylase deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/3124188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00207250

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/3124188

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46138563&oldid=2094256217"